About us
Our Science
EC-18 Technology Platform
Potential Therapeutic Indications
CRIOM
CIN
ARS
COVID-19
ICI Combination
NASH
Pipeline
News
Press Release
Enzychem in the News
Publications
Partner & Collaboration
Contact
About us
Our Science
EC-18 Technology Platform
Potential Therapeutic Indications
CRIOM
CIN
ARS
COVID-19
ICI Combination
NASH
Pipeline
News
Press Release
Enzychem in the News
Publications
Partner & Collaboration
Contact
About us
Our Science
EC-18 Technology Platform
Potential Therapeutic Indications
CRIOM
CIN
ARS
COVID-19
ICI Combination
NASH
Pipeline
News
Press Release
Enzychem in the News
Publications
Partner & Collaboration
Contact
News
May 12, 2020
Enzychem in the News
Enzychem Lifesciences to start P2 trial of COVID-19 treatment
Previous
Next
